Lucas J. O. Donnell

Array ( [id] => 7070214 [patent_doc_number] => 20050245599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same' [patent_app_type] => utility [patent_app_number] => 11/140838 [patent_app_country] => US [patent_app_date] => 2005-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 15758 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20050245599.pdf [firstpage_image] =>[orig_patent_app_number] => 11140838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7223922 [patent_doc_number] => 20050261201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Method of reducing C-reactive protein using growth hormone secretagogues' [patent_app_type] => utility [patent_app_number] => 11/094339 [patent_app_country] => US [patent_app_date] => 2005-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 16540 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20050261201.pdf [firstpage_image] =>[orig_patent_app_number] => 11094339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 672214 [patent_doc_number] => 07091226 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-15 [patent_title] => 'Cancer treatment with epothilones' [patent_app_type] => utility [patent_app_number] => 11/089269 [patent_app_country] => US [patent_app_date] => 2005-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25790 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/091/07091226.pdf [firstpage_image] =>[orig_patent_app_number] => 11089269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7069024 [patent_doc_number] => 20050244407 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Therapeutic synergy of anti-cancer compounds' [patent_app_type] => utility [patent_app_number] => 11/079064 [patent_app_country] => US [patent_app_date] => 2005-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4277 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20050244407.pdf [firstpage_image] =>[orig_patent_app_number] => 11079064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 217161 [patent_doc_number] => 07612071 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-03 [patent_title] => 'Compositions and methods employing aminopterin' [patent_app_type] => utility [patent_app_number] => 11/078614 [patent_app_country] => US [patent_app_date] => 2005-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22115 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/612/07612071.pdf [firstpage_image] =>[orig_patent_app_number] => 11078614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6931805 [patent_doc_number] => 20050282840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Methods of modulating neurotrophin-mediated activity' [patent_app_type] => utility [patent_app_number] => 11/057084 [patent_app_country] => US [patent_app_date] => 2005-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 32213 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20050282840.pdf [firstpage_image] =>[orig_patent_app_number] => 11057084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7250543 [patent_doc_number] => 20050272724 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Spin trapping pharmaceutical compositions and methods for use thereof' [patent_app_type] => utility [patent_app_number] => 11/053747 [patent_app_country] => US [patent_app_date] => 2005-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7477 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 43 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20050272724.pdf [firstpage_image] =>[orig_patent_app_number] => 11053747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7005754 [patent_doc_number] => 20050171067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Methods of treating disorders with group I mGluR antagonists' [patent_app_type] => utility [patent_app_number] => 11/015328 [patent_app_country] => US [patent_app_date] => 2004-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 29955 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20050171067.pdf [firstpage_image] =>[orig_patent_app_number] => 11015328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5160448 [patent_doc_number] => 20070173492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-26 [patent_title] => '1,2-Diaza-dibenzo[e,h]azulenes for the treatment of central nervous system diseases and disorders' [patent_app_type] => utility [patent_app_number] => 10/595934 [patent_app_country] => US [patent_app_date] => 2004-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8299 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20070173492.pdf [firstpage_image] =>[orig_patent_app_number] => 10595934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 840503 [patent_doc_number] => 07390833 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-24 [patent_title] => 'Method for treating ADAMTS-5-associated disease' [patent_app_type] => utility [patent_app_number] => 10/983981 [patent_app_country] => US [patent_app_date] => 2004-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 41895 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/390/07390833.pdf [firstpage_image] =>[orig_patent_app_number] => 10983981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5632312 [patent_doc_number] => 20060148782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Method and medicine for treating a mammal presenting urinary incontinence, urinary urgency, or both' [patent_app_type] => utility [patent_app_number] => 10/970174 [patent_app_country] => US [patent_app_date] => 2004-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5581 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20060148782.pdf [firstpage_image] =>[orig_patent_app_number] => 10970174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5045672 [patent_doc_number] => 20070264345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'Transdermal Pharmaceutical Composition' [patent_app_type] => utility [patent_app_number] => 10/575145 [patent_app_country] => US [patent_app_date] => 2004-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 20030 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 53 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20070264345.pdf [firstpage_image] =>[orig_patent_app_number] => 10575145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5711103 [patent_doc_number] => 20060052448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Use of methyl pyruvate or methyl pyruvic acid for the treatment of diseases of the nervous system and for protecting a human central nervous system against neuronal degeneration caused by defective intracellular energy production.' [patent_app_type] => utility [patent_app_number] => 10/711255 [patent_app_country] => US [patent_app_date] => 2004-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7021 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20060052448.pdf [firstpage_image] =>[orig_patent_app_number] => 10711255 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7137820 [patent_doc_number] => 20050181974 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists' [patent_app_type] => utility [patent_app_number] => 10/925368 [patent_app_country] => US [patent_app_date] => 2004-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7581 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20050181974.pdf [firstpage_image] =>[orig_patent_app_number] => 10925368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7163387 [patent_doc_number] => 20050085477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Compositions of a cyclooxygenase-2 selective inhibitor and a serotonin-modulating agent for the treatment of neoplasia' [patent_app_type] => utility [patent_app_number] => 10/922511 [patent_app_country] => US [patent_app_date] => 2004-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27250 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20050085477.pdf [firstpage_image] =>[orig_patent_app_number] => 10922511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5590439 [patent_doc_number] => 20060039890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Treatment of psychological and cognitive disorders using a cholesterol -lowering agent in combination with an antidepressant' [patent_app_type] => utility [patent_app_number] => 10/922652 [patent_app_country] => US [patent_app_date] => 2004-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5743 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20060039890.pdf [firstpage_image] =>[orig_patent_app_number] => 10922652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5667683 [patent_doc_number] => 20060173033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'Use of rapamycin and rapamycin derivatives for the treatment of bone loss' [patent_app_type] => utility [patent_app_number] => 10/563707 [patent_app_country] => US [patent_app_date] => 2004-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2565 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20060173033.pdf [firstpage_image] =>[orig_patent_app_number] => 10563707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5632438 [patent_doc_number] => 20060148908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Supressant of toxicity induced by cancer chemotherapeutic agent and composition of cancer chemotherapeutic agent containing the same' [patent_app_type] => utility [patent_app_number] => 10/562412 [patent_app_country] => US [patent_app_date] => 2004-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5978 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20060148908.pdf [firstpage_image] =>[orig_patent_app_number] => 10562412 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4444899 [patent_doc_number] => 07863272 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-04 [patent_title] => 'Sigma ligands for neuronal regeneration and functional recovery' [patent_app_type] => utility [patent_app_number] => 10/868423 [patent_app_country] => US [patent_app_date] => 2004-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12487 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/863/07863272.pdf [firstpage_image] =>[orig_patent_app_number] => 10868423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7318991 [patent_doc_number] => 20040224920 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Methods of treatment of mitochondrial disorders' [patent_app_type] => new [patent_app_number] => 10/868717 [patent_app_country] => US [patent_app_date] => 2004-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5412 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20040224920.pdf [firstpage_image] =>[orig_patent_app_number] => 10868717 [rel_patent_id] =>[rel_patent_doc_number] =>)